Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (30259)	1/14/2000 9:54:00 AM
From: Torben Noerup Nielsen	Read Replies (2) \| Respond to of 32384

Henry, If I remember correctly, Elan is bound by a fairly restrictive set of rules and they cannot mount a hostile take over attempt. I don't know if $30 would be unreasonable at this stage; you could well be right. However, just to add fuel to this speculative fire, what would Lilly and a few others be likely to do if Elan were to tender for the entire thing? Lilly and others have a substantial interest in this company as well and I believe they have the cash to make the acquisition or at least buy enough to prevent anyone from making the acquisition. Oh dear, we just made another wave on the chart... Now to see if we repeat the cycle. Thanks, Torben